Beryl Capital Management’s Medicus Sciences Acquisition Corp. Class A Ordinary Share MSAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-82,131
Closed -$803K 227
2022
Q1
$803K Sell
82,131
-7,202
-8% -$70.1K 0.05% 241
2021
Q4
$868K Buy
+89,333
New +$869K 0.04% 308

Other funds holding MSAC

Beryl Capital Management's MSAC Position: Q2 2022 in Review

Beryl Capital Management sold out of Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) in Q2 2022, closing a stake of 82,131 shares — an estimated $803K sold.

Beryl Capital Management first reported a position in MSAC in Q4 2021 and held it in 2 quarters. The position peaked at $868K in Q4 2021. 54 funds tracked by Wall St. Rank hold MSAC as of Q2 2022.

  • Beryl Capital Management reported no remaining Medicus Sciences Acquisition Corp. Class A Ordinary Share position as of Q2 2022 after selling out during the quarter.
  • Beryl Capital Management sold 82,131 Medicus Sciences Acquisition Corp. Class A Ordinary Share shares in Q2 2022, an estimated $803K.
  • Beryl Capital Management first reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share in Q4 2021 and held it in 2 quarters.
  • Beryl Capital Management's Medicus Sciences Acquisition Corp. Class A Ordinary Share position peaked at $868K in Q4 2021.
  • 54 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Class A Ordinary Share as of Q2 2022.

Based on Beryl Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.